No profile data available.
BioLineRx Ltd. (BLRX) is a healthcare company in the organ transfer treatment drugs industry, based in Hevel Modi'in, Israel, with about 20 full-time employees.
It reported revenue of $1.18 million for fiscal year 2025, down 95.9% from fiscal year 2024, and net income of -$1.18 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $294,000, down 3.3% from a year before. Its market capitalization was $11.03 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
BioLineRx reported $1.18 million in revenue for fiscal year 2025, down 95.9% from $28.94 million in fiscal year 2024. In Q2 2026 revenue was $294,000.
$11.03 million as of October 9, 2026.
Listed companies of a similar size in the same industry (organ transfer treatment drugs) include Omeros Corporation (OMER), Eledon Pharmaceuticals, Inc. (ELDN), Equillium, Inc. (EQ).